Mirae Asset Global Investments Co., Ltd.

Position in BCYC — Bicycle Therapeutics PLC

CIK 1569395 SEOUL, M5

Position in BCYC

as of Jun 30, 2026 · filed Jul 22, 2026 Compact

Position Value

$8,840

-$2,374 QoQ

Shares Held

2,085

-13.7% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#11

of 14 holders

Holding Since

Jun 2024

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Mirae Asset Global Investments Co., Ltd. holds $279,047,947 across 206 Biotechnology names. BCYC ranks #192 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	210,209	$104,417,115
2	REGN	Regeneron Pharmaceuticals, Inc.	93,632	$58,383,296
3	ALNY	Alnylam Pharmaceuticals, Inc.	61,531	$18,522,675
4	MDGL	Madrigal Pharmaceuticals, Inc.	33,420	$17,944,868
5	ARGX	Argenx SE	11,164	$10,357,623
6	ONC	BeOne Medicines Ltd.	33,808	$9,634,265
7	RPRX	Royalty Pharma plc	150,556	$8,441,674
8	INCY	Incyte Corp	63,812	$7,233,728

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$8,840	2,085	-13.7%	Shares	Sole	2026-07-22
2026-03-31	$11,214	2,417	+7.5%	Shares	Sole	2026-05-04
2025-12-31	$15,915	2,248	+25.8%	Shares	Sole	2026-01-26
2025-09-30	$13,831	1,787	+4.8%	Shares	Sole	2025-11-03
2025-06-30	$11,849	1,705	+16.5%	Shares	Sole	2025-07-21
2025-03-31	$12,429	1,464	-0.1%	Shares	Sole	2025-04-24
2024-12-31	$20,524	1,466	+9.2%	Shares	Sole	2025-01-27
2024-09-30	$30,369	1,342	+25.2%	Shares	Sole	2024-10-23
2024-06-30	$21,697	1,072	—	Shares	Sole	2024-07-30
No filing history on record for this holder in this stock.